Nucleus: payments to doctors
Payments that named Nucleus as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $416K
- Providers
- 675
- Transactions
- 1,847
- Average per transaction
- $225
The per-transaction average — $225 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 675 providers the average total is $617, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Cochlear Americas | $301,167 | 72.3% |
| Cochlear Ltd | $77,423 | 18.6% |
| Cochlear AG | $12,311 | 3.0% |
| Cochlear Bone Anchored Solutions AB | $10,922 | 2.6% |
| Cochlear Latinoamerica Sociedad Anonima | $9,408 | 2.3% |
| Nihon Cochlear Co Ltd | $5,057 | 1.2% |